Ropivacaine Hydrochloride

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 70069-063
  • Package NDC 70069-063-25
  • Application number ANDA207636
  • SPL ID 79b226f0-c08a-4f84-bf2b-ae5c60e01d67
  • SPL set ID ffeadbbf-4ca6-4ed8-94c1-6e0adf7fbe64
  • UNII V910P86109
  • RxCUI 905189
  • RxCUI 1734084
  • RxCUI 1734090
  • RxCUI 1734203
  • RxCUI 1734207
  • RxCUI 1734475
  • RxCUI 1734483

What the source publishes

Labeler
Somerset Therapeutics, LLC
Active ingredients
Ropivacaine Hydrochloride
Form
INJECTION
Routes
EPIDURAL, INFILTRATION, PERINEURAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:70069-063_79b226f0-c08a-4f84-bf2b-ae5c60e01d67
{
  "name": "Ropivacaine Hydrochloride",
  "splId": "79b226f0-c08a-4f84-bf2b-ae5c60e01d67",
  "labels": [
    {
      "setId": "ffeadbbf-4ca6-4ed8-94c1-6e0adf7fbe64",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ffeadbbf-4ca6-4ed8-94c1-6e0adf7fbe64",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ffeadbbf-4ca6-4ed8-94c1-6e0adf7fbe64"
    }
  ],
  "routes": [
    "EPIDURAL",
    "INFILTRATION",
    "PERINEURAL"
  ],
  "labeler": "Somerset Therapeutics, LLC",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "25 VIAL in 1 CARTON (70069-063-25)  / 20 mL in 1 VIAL (70069-063-01)",
      "package_ndc": "70069-063-25",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20180615"
    }
  ],
  "productId": "70069-063_79b226f0-c08a-4f84-bf2b-ae5c60e01d67",
  "useDomain": "unknown",
  "dosageForm": "INJECTION",
  "productNdc": "70069-063",
  "deaSchedule": null,
  "genericName": "Ropivacaine Hydrochloride",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "ROPIVACAINE HYDROCHLORIDE",
      "strength": "5 mg/mL"
    }
  ],
  "applicationNumber": "ANDA207636",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20180615",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "upc": [
      "0370069062104",
      "0370069062258",
      "0370069064252",
      "0370069061251",
      "0370069064016",
      "0370069063255",
      "0370069067017",
      "0370069066102",
      "0370069067109",
      "0370069063019",
      "0370069061015",
      "0370069065259",
      "0370069062012",
      "0370069064108",
      "0370069066256",
      "0370069067253",
      "0370069061107",
      "0370069066010",
      "0370069065013"
    ],
    "unii": [
      "V910P86109"
    ],
    "rxcui": [
      "905189",
      "1734084",
      "1734090",
      "1734203",
      "1734207",
      "1734475",
      "1734483"
    ],
    "spl_set_id": [
      "ffeadbbf-4ca6-4ed8-94c1-6e0adf7fbe64"
    ],
    "manufacturer_name": [
      "Somerset Therapeutics, LLC"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20261231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:70069-063_79b226f0-c08a-4f84-bf2b-ae5c60e01d67"